GEP20032968B - Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis - Google Patents

Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis

Info

Publication number
GEP20032968B
GEP20032968B GEAP19985410A GEAP1998005410A GEP20032968B GE P20032968 B GEP20032968 B GE P20032968B GE AP19985410 A GEAP19985410 A GE AP19985410A GE AP1998005410 A GEAP1998005410 A GE AP1998005410A GE P20032968 B GEP20032968 B GE P20032968B
Authority
GE
Georgia
Prior art keywords
atherosclerosis
ketolides
pharmaceutical compositions
preventing thrombotic
arterial complications
Prior art date
Application number
GEAP19985410A
Other languages
English (en)
Inventor
Francoise Vacheron
Francis Petit
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of GEP20032968B publication Critical patent/GEP20032968B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GEAP19985410A 1997-11-17 1998-11-16 Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis GEP20032968B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
GEP20032968B true GEP20032968B (en) 2003-05-27

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19985410A GEP20032968B (en) 1997-11-17 1998-11-16 Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis

Country Status (35)

Country Link
US (1) US20080139489A1 (enExample)
EP (1) EP1030673B1 (enExample)
JP (1) JP4550273B2 (enExample)
KR (1) KR20010032130A (enExample)
CN (1) CN1286633A (enExample)
AP (1) AP1196A (enExample)
AR (1) AR014119A1 (enExample)
AT (1) ATE271875T1 (enExample)
AU (1) AU744419B2 (enExample)
BG (1) BG104427A (enExample)
BR (1) BR9814199A (enExample)
CA (1) CA2312021C (enExample)
DE (1) DE69825308T2 (enExample)
DZ (1) DZ2654A1 (enExample)
EA (1) EA003322B1 (enExample)
EE (1) EE04095B1 (enExample)
ES (1) ES2224446T3 (enExample)
FR (1) FR2771008B1 (enExample)
GE (1) GEP20032968B (enExample)
HR (1) HRP20000314A2 (enExample)
HU (1) HUP0004507A3 (enExample)
ID (1) ID24940A (enExample)
IL (1) IL136149A0 (enExample)
MA (1) MA26566A1 (enExample)
NO (1) NO20002435L (enExample)
NZ (1) NZ504305A (enExample)
OA (1) OA11411A (enExample)
PL (1) PL340373A1 (enExample)
SK (1) SK7042000A3 (enExample)
TN (1) TNSN98206A1 (enExample)
TR (1) TR200001384T2 (enExample)
TW (1) TW472061B (enExample)
WO (1) WO1999025365A1 (enExample)
YU (1) YU29600A (enExample)
ZA (1) ZA9810357B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ES2273964T3 (es) * 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
IL144178A0 (en) * 1999-01-27 2002-05-23 Pfizer Prod Inc Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
IL151887A0 (en) 2000-04-04 2003-04-10 Smithkline Beecham Plc 2-hydroxy-mutilin carbamate derivatives for antibacterial use
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
US9815863B2 (en) * 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2249892A (en) * 1991-06-14 1993-01-12 Board Of Regents Of The University Of Washington, The Diagnosis and treatment of arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
EE200000244A (et) 2001-06-15
NZ504305A (en) 2002-11-26
FR2771008A1 (fr) 1999-05-21
OA11411A (fr) 2004-04-20
PL340373A1 (en) 2001-01-29
CA2312021C (fr) 2008-08-26
JP2001523644A (ja) 2001-11-27
HUP0004507A3 (en) 2001-12-28
NO20002435L (no) 2000-07-07
AU1242599A (en) 1999-06-07
TNSN98206A1 (fr) 2005-03-15
EP1030673A1 (fr) 2000-08-30
US20080139489A1 (en) 2008-06-12
EE04095B1 (et) 2003-08-15
TR200001384T2 (tr) 2001-06-21
IL136149A0 (en) 2001-05-20
EA003322B1 (ru) 2003-04-24
TW472061B (en) 2002-01-11
DE69825308T2 (de) 2005-08-04
JP4550273B2 (ja) 2010-09-22
YU29600A (sh) 2003-02-28
FR2771008B1 (fr) 2000-04-28
HRP20000314A2 (en) 2001-02-28
CA2312021A1 (fr) 1999-05-27
ATE271875T1 (de) 2004-08-15
AP2000001825A0 (en) 2000-06-30
KR20010032130A (ko) 2001-04-16
ZA9810357B (en) 1999-11-12
AP1196A (en) 2003-08-18
AU744419B2 (en) 2002-02-21
ID24940A (id) 2000-08-31
BR9814199A (pt) 2000-09-26
MA26566A1 (fr) 2004-12-20
EP1030673B1 (fr) 2004-07-28
HUP0004507A1 (hu) 2001-05-28
NO20002435D0 (no) 2000-05-11
WO1999025365A1 (fr) 1999-05-27
CN1286633A (zh) 2001-03-07
DE69825308D1 (de) 2004-09-02
BG104427A (en) 2001-02-28
AR014119A1 (es) 2001-02-07
ES2224446T3 (es) 2005-03-01
DZ2654A1 (fr) 2003-03-22
SK7042000A3 (en) 2000-12-11
EA200000531A1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
MY132705A (en) Novel compounds with analgesic effect
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
MY115662A (en) Novel compounds with analgesic effect
CA2274074A1 (en) Novel compounds with analgesic effect
CA2293823A1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
CA2268097A1 (en) Sulfinic acid derivatives and their preparation and use
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
CA2289717A1 (en) Novel therapy for constipation
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
MY115211A (en) Novel amino acid derivatives, their preparation and use
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
GEP20032968B (en) Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
CA2279184A1 (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine